Post Hoc Analysis Evaluating the Impact of Antihyperglycemic Background Therapies on Attainment of A1C Targets Without Hypoglycemia in the ACHIEVE Control Pragmatic, Real-Life Study

BACKGROUND: ACHIEVE Control, a prospective, open-label, randomized, pragmatic, real-life study in insulin-naive people with type 2 diabetes (A1C 8.0–11.0%), demonstrated superiority of insulin glargine 300 units/mL (Gla-300) versus first-generation standard-of-care basal insulin (SOC-BI; glargine 10...

Descripción completa

Detalles Bibliográficos
Autores principales: Bailey, Timothy S., Evenou, Pierre, Gill, Jasvinder, Berhanu, Paulos, Raymond, Romain, Strong, Jodi, Wright, Eugene E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2021
Materias:
Feature Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603128/
https://www.ncbi.nlm.nih.gov/pubmed/34866875
http://dx.doi.org/10.2337/ds20-0079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603128/
https://www.ncbi.nlm.nih.gov/pubmed/34866875
http://dx.doi.org/10.2337/ds20-0079

Ejemplares similares